XML 38 R27.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes (Details Narrative)
12 Months Ended
Sep. 30, 2015
USD ($)
Income Tax Disclosure [Abstract]  
Deferred tax asset $ 10,647,527
Net operating loss carry forwards 31,316,257
Amount of NOL acuired in reverse aquisition fo BMSG 38,616
Amount of NOL attributable to Bio-Matrix Scientific Group, Inc, BMSG and Regen. $ 31,277,641
Federal Corporate income tax Rate 34.00%